Body Image, Self-stigma, Intuitive Eating and Exercise Behavior in Overweight and Obese

June 30, 2021 updated by: Nur Elcin Boyacıoglu, Istanbul University - Cerrahpasa (IUC)

Investigation of Body Image, Self-stigma, Intuitive Eating and Exercise Behavior in Overweight and Obese

This study, it was aimed to investigate the relationship between body image, self-stigma, intuitive eating and exercise attitude levels, which are thought to be effective on the mental well-being of overweight and obese individuals. For this purpose, the Body Image Scale, Intuitive Eating Scale-2, Exercise Stages of Change Scale-Short Form and Decisional Balance Scale in Exercise will be used to assess overweight and obese individuals. 100 people will be included in the study.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Kadıköy
      • Istanbul, Kadıköy, Turkey, 34714
        • DiyeTat-Beslenme ve Danışmanlık

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Overweight and obese individuals between the ages of 18-65 will be included in the study.

Description

Inclusion Criteria:

  • Individuals aged between 18-65
  • BMI ≥30 kg/m2,
  • No surgical operation in the last 6 months

Exclusion Criteria:

  • Musculoskeletal disorders or systemic diseases that may prevent exercise
  • The presence of psychiatric or neurological disease affecting cooperation and cognitive functions
  • Presence of acute pain
  • Heart pain
  • Presence of previous myocardial infarction, subjective heart failure, uncontrolled diabetes and hypertension

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Image Scale
Time Frame: Baseline
It was developed by Secord and Jourand in 1953, and was adapted to Turkish society after being validated and reliable by Hovardaoğlu in 1989. The scale includes 40 items and each item is related to an organ or a part of the body (such as arm, leg, face) or a function (such as sexual activity level).
Baseline
Intuitive Eating Scale-2
Time Frame: Baseline
The Intuitive Eating Scale-2 was developed by Tylka and Kroon Van Diest (2013) to measure intuitive eating behaviors. The scale consists of 21 questions and four sub-titles.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Stages of Change Scale-Short Form
Time Frame: Baseline
This 5-optioned scale evaluates the changes of exercise behavior of participants in five stages of pre contemplation, contemplation, preparation, action, and consistency. Participants have to select one of the 5 options that evaluate the intention to participate in physical activity and sports now and in the future.
Baseline
Decisional Balance Scale in Exercise
Time Frame: Baseline
The scale is used to measure the individual decision to exercise with 10 questions designed to evaluate exercise beliefs (positive beliefs and obstacles). Participants are asked to choose on a 5-point Likert scale, in what way important every statement was with respect to their intentions to exercise, or not.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nur Elçin Boyacıoğlu, Assist Prof, Istanbul Universitesi-Cerrahpasa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

August 1, 2021

Primary Completion (ANTICIPATED)

September 15, 2021

Study Completion (ANTICIPATED)

October 1, 2021

Study Registration Dates

First Submitted

June 30, 2021

First Submitted That Met QC Criteria

June 30, 2021

First Posted (ACTUAL)

July 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 9, 2021

Last Update Submitted That Met QC Criteria

June 30, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IstanbulUC9325

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe